Х.Цэвэлноров
Loading...
Товч нэр
Х.Цэвэлноров
Бүтэн нэр
Хүрэлбаатар Цэвэлноров
Латин нэр
Khurelbaatar Tsevelnorov
Албан тушаал
Багш
ORCID
Scopus Author ID
4 results
Now showing 1 - 4 of 4
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Initial results of screening program in Mongolia where burdening high gastric cancer – Multi center study(Thieme Medical Publishers (Germany), 2024-04-01); ;G. Boldbaatar; ;Sarantuya TserenchimedD. JambalAims Background: Mongolia is the leading country by the incidence and mortality rate of gastric. In 2022 national cancer screening program for upper gastrointestinal neoplasia was initiated therefore we conducted the multi-center study for determining the gastric cancer among Mongolian population. Methods Methods: The cross sectional study was performed to screen the precancerous lesion (LGD, Atypia) and cancerous lesion (HGD, adenocarcinoma, signet cell carcinoma etc.) assessed among the people who underwent gastric endoscopy in 28 endoscopy centers in Mongolia during from May of 2022 to September of 2022. (Endoscopic centers of Ulaanbaatar city's 9 district and 21 provinces). The primary outcomes of this study was to define detection rate (proportion of positive cases among individuals who underwent endoscopic screening) and to determine the characteristics of cancer type including its precursor disease. Results Results: Totally 34,581 people were screened from May 2022 to September 2022. Among them n=262 (0.8%) patients diagnosed with gastric cancer based on endoscopic examination. The proportion of early stage gastric cancer was n=135 (51.5%) of all screened cancer cases. Conclusions Conclusion: The initiation of Mongolian national gastric cancer screening program was useful to detect gastric cancer in early stage which further can reduce mortality rate of gastric cancer due to its treatment possibilities. Therefore, national screening program should be continuous. [ 1 ] [ 2 ] [ 3 ] [ 4 ] [ 5 ] [ 6 ] [ 7 ] [ 8 ] [ 9 ] [ 10 ] [ 11 ] [ 12 ] [ 13 ] [ 14 ] [ 15 ] [ 16 ] [ 17 ] [ 18 ] [ 19 ] [ 20 ] [ 21 ] [ 22 ] [ 23 ] [ 24 ] Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany - Some of the metrics are blocked by yourconsent settings
Item type:Publication, IDDF2023-ABS-0226 Initial results of screening program in mongolia where burdening high gastric cancer(2023-06-01); ; ;Sarantuya Tserenchimed; Background Mongolia is the leading country in the incidence and mortality rate of gastric cancer. According to the national data, TNM stage at the time of cancer diagnosis, a gastric cancer diagnosis is 0.4% in the carcinoma-in-situ stage, 5.1% in stage I, 15.2% in stage II, 42.7% in stage III and 36.5% in stage IV 36.5% were diagnosed respectively. Whereas almost 80% of people are diagnosed with early-stage of gastric cancer in Japan and Korea, where national cancer screening programs have been initiated for several decades. In 2022 national cancer screening program for upper gastrointestinal neoplasia was initiated; therefore, we aimed to conduct a multi-center study to determine gastric cancer incidence among the Mongolian population. Methods The cross-sectional study was performed to examine the detection rate of gastric cancer cases based on a national screening program from May to December 2022. The primary outcomes of this study were to define the detection rate (proportion of positive cases among individuals who underwent endoscopic screening) and to determine the characteristics of the cancer type, including its precursor disease based on histological examination. Results During the screening program, a total of 34581 participants’ data were collected from 28 endoscopy centers from Ulaanbaatar city and the western eastern, southern, and northern parts of the Mongolian province’s hospitals. The age range of the study participants was 35 to 93 years old. In terms of gender, 56.8% are men and 43.13% are women. The mean with SD age of people diagnosed with gastric cancer was 61.56±1.11, while the mean with SD age of healthy people was 53.84 ± 0.29 (p-value 0.0001). Among them, 113 (0.1%) patients were diagnosed with gastric cancer. The proportion of early-stage gastric cancer cases was 34 (30%) based on endoscopic and histological evaluation. The overall cases included in the national screening program are summarized in Figure 1 (IDDF2023-ABS-0226 Figure 1. Initial result from the national screening program for gastric cancer). Conclusions The initiation of the Mongolian national gastric cancer screening program could increase to detect the proportion of gastric cancer in its early stage. Therefore, screening programs should be continuous further. However, the quality of endoscopic examination should be improved. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Ходоодны хорт хавдрын тохиолдлыг эрт илрүүлэг шинжилгээгээр судалсан үр дүн(2024-01-28) ;Ж.Билгүүн; ;Ц.Сарантуяа ;Х.ОюунцэцэгҮндэслэл: Монгол улс ходоодны хорт хавдрын өвчлөл болон нас баралтын түвшнээрээ дэлхий дахинд тэргүүлсээр байна. Иймд 2022 оноос эхлэн Монгол улсад улаан хоолой ходоодны хорт хавдраас урьдчилан сэргийлэх, эрт илрүүлэх үндэсний хөтөлбөрийг хэрэгжүүлж хүн амын дунд ходоодны хорт хавдрын эрт илрүүлгийн түвшинг тодорхойлох олон төвт судалгааг хийсэн. Зорилго: Ходоодны хавдрын эрт болон хожуу үеийн илрүүлгийн үр дүн, эрт үеийн хавдрын илрүүлэлтийн түвшинг судлах. Арга, аргачлал: 2022 оны 5 дугаар сараас 2023 оны 5 дугаар сарын хооронд буюу 1 жилийн хугацаанд Монгол улсын 28 дурангийн төвд ходоодны дурангийн шинжилгээнд хамрагдсан хүмүүсийн доторх хорт хавдрын урьдал эмгэг (бага түвшинт дисплази, эсийн атип) болон хорт хавдар (өндөр түвшинт дисплази, аденокарцинома, сигнет эсийн хорт хавдар гэх мэт)-ыг илрүүлэх зорилгоор олон төвт ретроспектив судалгааг хийсэн. (Улаанбаатар хотын 9 дүүрэг, 21 аймгийн дурангийн төвүүд). Энэхүү судалгааны үндсэн үр дүн нь эрт илрүүлэлтийн түвшинг тодорхойлох (эндоскопийн шинжилгээнд хамрагдсан хүмүүсийн эерэг тохиолдлын эзлэх хувь), хорт хавдрын төрөл, түүний дотор түүний урьдал өвчний шинж чанарыг тодорхойлох явдал байв. Үр дүн: Бидний судалгаанд 2022 оны 5 дугаар сараас 2023 оны 5 дугаар сар хүртэл нийт 67634 хүн хамрагдсанаас дурангийн шинжилгээгээр 402 буюу нийт хүмүүсийн 0.5% нь ходоодны хорт хавдартай гэж оношлогдсон байна. Ходоодны хорт хавдрын эрт үе шатанд өвчлөгсдийн эзлэх хувь 56.9% байна. Дүгнэлт: 1. Ходоодны хавдрын бус өөрчлөлтийн хувьд эдийн шинжилгээнд бага түвшинт дисплази өөрчлөлт давамгай илэрч байна 2. Ходоод-улаан хоолойн хорт хавдраас урьдчилан сэргийлэх үндэсний хөтөлбөрийг эхлүүлсэн нь ходоодны хорт хавдрыг эрт үед нь илрүүлэх, эмчлэх боломжийг тогтоосноор ходоодны хорт хавдрын шалтгаант нас баралтыг бууруулах ач холбогдолтой байгаа нь уг хөтөлбөрийг тасралтгүй хэрэгжүүлэх шаардлагатайг харуулж байна.
